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O
ver the past year the pandemic of non–commu-
nicable diseases (NCDs) has become a key focus 
of global political agenda. At the United Nations' 
high–level meeting on the prevention and control of NCDs 
in September 2011, a general consensus has been reached 
that NCDs were already the leading causes of death in all 
world regions and that their burden is increasing rapidly 
[1]. The rate of this increase is particularly striking in low– 
and middle–income countries (LMICs), where life expec-
tancy is increasing as a result of improved socio–economic 
conditions [2]. It is expected that by the year 2030, NCDs 
could become responsible for 52 million deaths [3]. In 
LMICs, health systems will face considerable challenge in 
adjusting to the rapidly growing demand for services, and 
this could in turn become an additional significant barrier 
to achieving the Millennium Development Goals [2]. As a 
result, many parallel advocacy efforts for tackling NCDs 
are taking place, with a particular focus on heart disease, 
cancer, respiratory diseases, diabetes and stroke [4]. A 
number of interventions have been outlined that could 
have immediate preventive effect and slow down the pan-
demic, such as tobacco control, improved diet, exercise 
and decreased alcohol intake [4].
The release of the new global burden of disease (GBD) es-
timates for the year 2010, by the Institute for Health Met-
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Non-communicable causes of death and disability will dominate global health agenda for the foreseeable 
future. The progress in addressing their burden and achieving measurable reduction in low– and middle–
income countries (LMICs) will likely require similar steps that were effective in reducing maternal and 
child mortality globally: (i) defining the size of the burden and the main causes responsible for the major-
ity of the burden; (ii) understanding the most important risk factors and their importance in different con-
texts; (iii) systematically assessing the effectiveness and cost of the interventions that are feasible and 
available in LMICs; and (iv) formulating evidence–based health policies that will define appropriate health 
care and health research priorities to tackle the burden in the most cost–effective way.
rics and Evaluation (IHME) at the University of Washing-
ton in Seattle, is anticipated with great interest [5]. The new 
revision is expected to show substantial progress in the re-
duction of maternal and child mortality in the LMICs over 
the past two decades. However, many fear that there will 
be hardly any measurable progress in improving health and 
survival of adult populations in LMICs. The UN conference 
in 2011 and the publication of the new GBD estimates 
could therefore mark the beginning of the era in which 
non–communicable causes of death and disability will 
dominate global health agenda for the foreseeable future. 
The progress in addressing their burden and achieving 
measurable reduction in LMICs will likely require similar 
steps that were effective in reducing maternal and child 
mortality globally: (i) defining the size of the burden and 
the main causes responsible for the majority of this burden; 
(ii) understanding the most important risk factors and their 
importance in different contexts; (iii) systematically assess-
ing the effectiveness and cost of the interventions that are 
feasible and available within the contexts of different 
LMICs; and (iv) formulating evidence–based health poli-
cies that will define appropriate health care and health re-
search priorities to tackle the burden in the most cost–ef-
fective way.
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The first step in this process is to measure the burden of 
NCDs in LMICs. This is a challenging task given the scar-
city of available data, inconsistency in case definitions of 
the measured diseases, differences in reporting of results 
(eg, age groups) used by different investigators, lack of 
funding, research infrastructure and capacity for commu-
nity–based studies in LMICs, changing definitions of dis-
eases over time, low transcultural adaptability of screening 
instruments, and many others [6-8]. Methodological ap-
proaches that could take into account the diversity and 
scarcity in the available information and produce accept-
able regional estimates using transparent and sound meth-
Measuring the burden of non–communica-
ble diseases in low–resource settings is a 
challenging task given the scarcity of avail-
able data, inconsistency in case definitions 
of the measured diseases, differences in re-
porting of results used by different investi-
gators, lack of funding, research infrastruc-
ture and capacity for community–based 
studies, changing definitions of diseases 
over time, low transcultural adaptability of 
screening instruments, and many others.
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odological approaches are urgently needed. Furthermore, 
the international research community could benefit from 
clear guidelines on conducting epidemiological studies in 
LMICs that could inform burden of disease analyses, so that 
research results are comparable and leading to more reli-
able estimates.
In the current issue of the Journal of Global Health, we are 
publishing several studies that attempt to summarise infor-
mation on the burden of non–communicable diseases and 
provide estimates for a region that has traditionally been 
considered “information gaps”: the African continent. The 
papers by George-Carey et al. [9], Paul et al. [10], Graham 
et al. [11] and Dowman et al. [12] provide the first system-
atic estimates of the burden of dementia, epilepsy and rheu-
matoid arthritis, respectively. In addition, Reidpath and Al-
lotey provide an authoritative viewpoint on the changing 
chronic disease management in LMICs [13], Moten et al. 
discuss the challenge of equitable building of public health 
infrastructure in low resource settings [14], Kolcic warns of 
the “double burden of malnutrition” as a silent driver of the 
NCD pandemic [15], while Maher and Sridhar address the 
role of political priority in the global fight against NCDs 
[16]. In the future issues of our journal, we will increasing-
ly welcome similar attempts to quantify disease burden, the 
role of risk factors and the effectiveness of interventions tar-
geted at reducing NCDs in low resource settings.
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